Andira Medicine Inc. files Form D
Sold rose to $NaN (+$710K, +4 investors) in 17 days since the previous filing.
Andira Medicine Inc., a British Columbia corporation, raised $120K under Regulation D exemption 6(b). The offering closed on September 24, 2026, with one investor and North Point Mergers and Acquisitions listed as placement agent.
Note: Micro-sized raise ($120K) with single investor; verify investor accreditation status given exemption 6(b) and minimal documentation trail.
Computed from every Form D fund launch on EDGAR since late 2024, not sampled. Amounts are the stated offering size; indefinite offerings are excluded.
| Filed | Form | Sold | Investors | Change |
|---|---|---|---|---|
| 2025-09-05 | D/A | $810K | 5 | |
| 2026-03-12 | D | $152K | 3 | −$658K |
| 2026-08-18 | D | $100K | 1 | −$52K |
| 2026-09-04 | D/A | $810K | 5 | +$710K |
| 2026-10-09 | D | $120K | 1 | −$690K |
Amount sold and investor count as restated on each of the issuer's Form D filings. A rise since the previous filing is capital closed in between.
Earlier and related filings by the same issuer and sponsor.
Sold rose to $NaN (+$710K, +4 investors) in 17 days since the previous filing.
| Dana Lambert | Director, Executive Officer |
| Ethan Russo | Director, Executive Officer |
| Michael Stuart Wall | Director, Executive Officer |
| Ammad Shorbaji | Executive Officer |
| Janette Lyons | Executive Officer |
Signed by Dana Lambert, CEO.
Placement agents / sales compensation: North Point Mergers and Acquisitions, Inc.
The issuer's phone number and address from the filing are shown to subscribers. See plans.